Anthony Nieves discusses ISM Services data, Kim Forrest shares market outlook, Tim Craighead highlights 10 companies to watch, Matt Winkler talks about Biden's jobs power in Georgia. Michael Stubblefield discusses life sciences opportunities. The podcast covers service sector growth, industry hiring trends, top companies, Tencent's potential, AI future, Georgia's economy, and innovation in the pharmaceutical industry.
A Van Door's strong foothold in biopharma and healthcare sectors drives future growth prospects.
Talent acquisition and development are crucial for A Van Door's global presence and customer-centric approach.
Deep dives
A Van Door: Supporting Innovation in the Life Sciences
A Van Door is deeply embedded in the biopharma and biotech space, serving a wide range of customers from traditional large pharma companies to startups and biotech firms. They provide a vast array of products, including chemicals, reagents, instruments, and consumables for research labs worldwide. With a focus on efficiency and productivity, A Van Door aims to enable scientists to focus on developing breakthrough therapies.
A Van Door's Impacts During the Pandemic
During the pandemic, A Van Door played a crucial role in supplying materials for vaccine production and COVID-19 testing. They faced challenges due to supply chain constraints and increased demand for pandemic-related workflows. As the situation normalized, the company experienced headwinds from supply chain normalization and procurement trends.
A Van Door's Outlook for Growth and Profitability
A Van Door's strong positioning in the biopharma, biotech, and healthcare sectors, which account for over 60% of their revenues, bodes well for future growth. With record drug approvals, robust pipelines, and innovative therapeutic platforms driving the industry, the company anticipates leveraging market momentum for a strong setup. Overcoming challenges like inventory de-stocking and supply chain constraints, A Van Door is optimistic about its growth trajectory.
Talent and Hiring at A Van Door
Talent is critical for A Van Door, with over 14,000 global associates driving the company's growth and customer service efforts. The company values its workforce and continuously adds capabilities to serve new modalities like cell and gene therapy. With a global presence in 180 countries, A Van Door remains committed to nurturing talent and ensuring capabilities align with customer needs.
Anthony Nieves, Chair of the ISM Services Business Committee, discusses ISM Services data. Tim Craighead, Bloomberg Intelligence Research Director for Content, talks about his column on “Houses, Hotels, Software and Tires: 10 Companies to Watch Now.” Kim Forrest, Founder and CIO of Bokeh Capital Partners, discusses her outlook for the markets. Matt Winkler, Bloomberg News Editor and Chief Emeritus, joins to discuss his latest column: “Biden's Record Jobs Power Swing State Georgia.” Michael Stubblefield, President and CEO at Avantor, discusses opportunities in the life sciences industry, and what will fuel the company's continued growth.